---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-22-000005"
form_type: "8-K"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2022-01-07T23:59:59+00:00"
generated_at: "2026-06-27T20:01:55.024010+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# ICU Medical completes acquisition of Smiths Medical for $1.85B cash + stock

## Summary
- Paid $1.85B cash and issued 2.5M shares of ICUI common stock; up to $100M additional contingent cash.
- Entered into $2.2B Credit Facilities: $850M Term Loan A, $850M Term Loan B, $500M revolver.
- Pro forma combined revenue approximately $2.5 billion; Smiths adds infusion, vascular, vital care products.
- Seller (Smiths Group) gets board seat if owns >5% of ICUI; share transfer restricted for 6 months.
- Company plans to provide full FY 2022 guidance on Q4 earnings call in late February.

## SEC filing metadata
- accession: 0000883984-22-000005
- form_type: 8-K
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2022-01-07T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 2.01, 2.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398422000005/0000883984-22-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398422000005/icui-20220107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-22-000005
- JSON: https://secwatch.observer/filing/0000883984-22-000005.json
- Plain text: https://secwatch.observer/filing/0000883984-22-000005.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.